Literature DB >> 18632600

XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from molecular pathogenesis to targeted therapy in leukemia and solid tumors.

Björn Hackanson1, Heiko Becker, Tobias Berg, Mascha Binder, Christine Dierks, Jesús Duque-Afonso, Michael D Lairmore, Henning S Schäfer, Marc Schnitzler, Robert Zeiser, Uwe Martens, Roland Mertelsmann, Michael Lübbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18632600      PMCID： PMC3147145          DOI： 10.1158/0008-5472.CAN-07-6859

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  27 in total

1.  RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides.

Authors:  Kathrin Matzen; Lina Elzaouk; Alexey A Matskevich; Anja Nitzsche; Jochen Heinrich; Karin Moelling
Journal:  Nat Biotechnol       Date:  2007-06-03       Impact factor: 54.908

2.  A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.

Authors:  Ming Yan; Eiki Kanbe; Luke F Peterson; Anita Boyapati; Yuqin Miao; Yang Wang; I-Ming Chen; Zixing Chen; Janet D Rowley; Cheryl L Willman; Dong-Er Zhang
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

Review 3.  Knockout mouse models to study Wnt signal transduction.

Authors:  Renée van Amerongen; Anton Berns
Journal:  Trends Genet       Date:  2006-10-11       Impact factor: 11.639

4.  Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Authors:  Alan List; Gordon Dewald; John Bennett; Aristotle Giagounidis; Azra Raza; Eric Feldman; Bayard Powell; Peter Greenberg; Deborah Thomas; Richard Stone; Craig Reeder; Kenton Wride; John Patin; Michele Schmidt; Jerome Zeldis; Robert Knight
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

5.  Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.

Authors:  Francesco Fazi; Giuseppe Zardo; Vania Gelmetti; Lorena Travaglini; Alberto Ciolfi; Luciano Di Croce; Alessandro Rosa; Irene Bozzoni; Francesco Grignani; Francesco Lo-Coco; Pier Giuseppe Pelicci; Clara Nervi
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

6.  Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

Authors:  Jorge Cortes; Philippe Rousselot; Dong-Wook Kim; Ellen Ritchie; Nelson Hamerschlak; Steven Coutre; Andreas Hochhaus; Francois Guilhot; Giuseppe Saglio; Jane Apperley; Oliver Ottmann; Neil Shah; Philipp Erben; Susan Branford; Prasheen Agarwal; Ashwin Gollerkeri; Michele Baccarani
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

7.  Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Krzysztof Mrózek; Hankui Chen; Rick A Kittles; Tamara Vukosavljevic; Danilo Perrotti; James W Vardiman; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

8.  Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

Authors:  Andreas Mackensen; Norbert Meidenbauer; Sandra Vogl; Monika Laumer; Jana Berger; Reinhard Andreesen
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

9.  A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Authors:  Alan K Burnett; Donald Milligan; Archie G Prentice; Anthony H Goldstone; Mary F McMullin; Robert K Hills; Keith Wheatley
Journal:  Cancer       Date:  2007-03-15       Impact factor: 6.860

10.  Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.

Authors:  Aparna Raval; Stephan M Tanner; John C Byrd; Elizabeth B Angerman; James D Perko; Shih-Shih Chen; Björn Hackanson; Michael R Grever; David M Lucas; Jennifer J Matkovic; Thomas S Lin; Thomas J Kipps; Fiona Murray; Dennis Weisenburger; Warren Sanger; Jane Lynch; Patrice Watson; Mary Jansen; Yuko Yoshinaga; Richard Rosenquist; Pieter J de Jong; Penny Coggill; Stephan Beck; Henry Lynch; Albert de la Chapelle; Christoph Plass
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.